Targeting V-1A-vasopressin receptors with [Arg(6), D-Trp(7,9), N(me)Phe(8)]-substance P (6-11) identifies a strategy to develop novel anti-cancer therapies

Alison C. MacKinnon, Uzma Tufail-Hanif, Mark Wheatley, Adriano G. Rossi, Christopher Haslett, Michael Seckl, Tariq Sethi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Targeting V-1A-vasopressin receptors with [Arg(6), D-Trp(7,9), N(me)Phe(8)]-substance P (6-11) identifies a strategy to develop novel anti-cancer therapies'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science